Edition:
India

Alkermes And Clovis Oncology Initiate Research Collaboration To Explore Combination Cancer Therapies


Tuesday, 19 Feb 2019 

Feb 19 (Reuters) - Alkermes Plc ::ALKERMES AND CLOVIS ONCOLOGY INITIATE RESEARCH COLLABORATION TO EXPLORE COMBINATION CANCER THERAPIES.CLOVIS ONCOLOGY INC - COMBINATIONS OF ALKS 4230 WITH RUCAPARIB AND LUCITANIB TO BE EVALUATED IN MULTIPLE PRECLINICAL TUMOR MODELS.CLOVIS - COMPANIES WILL SHARE COSTS RELATED TO PRECLINICAL STUDIES, AND EACH WILL CONTRIBUTE THEIR RESPECTIVE COMPOUNDS TO RESEARCH COLLABORATION..